13 Hrs
Source:
الاقتصادية
Arabio covers 79% of Saudi vaccines
Arabio Company specializes in producing adult vaccines in Saudi Arabia, covering approximately 79% of the local vaccine market. The company has plans to enhance its manufacturing capabilities to fully localize the entire technology value chain within the kingdom. Currently, it is in the early stages of manufacturing, including secondary packaging, with gradual plans to advance to more sophisticated stages such as final filling and assembly. The goal is to strengthen supply chain resilience and reduce dependence on imports. Over the past years, the company has delivered around 70 million doses and has exported its products to Gulf countries, the Levant, and North Africa. It aims to expand its regional presence and has invested about half a billion riyals over the past 20 years in vaccine manufacturing and supporting local capabilities, with the objectives of achieving pharmaceutical security and independently meeting both local and regional demand.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)